Arizona State Retirement System’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $354K | Buy |
17,419
+312
| +2% | +$6.35K | ﹤0.01% | 1637 |
|
2025
Q1 | $310K | Sell |
17,107
-195
| -1% | -$3.54K | ﹤0.01% | 1660 |
|
2024
Q4 | $437K | Buy |
17,302
+222
| +1% | +$5.61K | ﹤0.01% | 1557 |
|
2024
Q3 | $581K | Buy |
17,080
+849
| +5% | +$28.9K | ﹤0.01% | 1408 |
|
2024
Q2 | $601K | Buy |
16,231
+325
| +2% | +$12K | ﹤0.01% | 1322 |
|
2024
Q1 | $668K | Buy |
15,906
+2,148
| +16% | +$90.2K | ﹤0.01% | 1275 |
|
2023
Q4 | $546K | Buy |
13,758
+2,322
| +20% | +$92.1K | ﹤0.01% | 1394 |
|
2023
Q3 | $315K | Buy |
11,436
+165
| +1% | +$4.54K | ﹤0.01% | 1637 |
|
2023
Q2 | $382K | Buy |
11,271
+354
| +3% | +$12K | ﹤0.01% | 1568 |
|
2023
Q1 | $393K | Buy |
10,917
+359
| +3% | +$12.9K | ﹤0.01% | 1546 |
|
2022
Q4 | $471K | Buy |
10,558
+394
| +4% | +$17.6K | ﹤0.01% | 1415 |
|
2022
Q3 | $286K | Buy |
10,164
+47
| +0.5% | +$1.32K | ﹤0.01% | 1665 |
|
2022
Q2 | $273K | Buy |
10,117
+26
| +0.3% | +$702 | ﹤0.01% | 1732 |
|
2022
Q1 | $344K | Buy |
10,091
+83
| +0.8% | +$2.83K | ﹤0.01% | 1708 |
|
2021
Q4 | $387K | Sell |
10,008
-542
| -5% | -$21K | ﹤0.01% | 1688 |
|
2021
Q3 | $570K | Sell |
10,550
-205
| -2% | -$11.1K | ﹤0.01% | 1458 |
|
2021
Q2 | $360K | Sell |
10,755
-763
| -7% | -$25.5K | ﹤0.01% | 1762 |
|
2021
Q1 | $237K | Buy |
11,518
+171
| +2% | +$3.52K | ﹤0.01% | 1943 |
|
2020
Q4 | $199K | Buy |
+11,347
| New | +$199K | ﹤0.01% | 1962 |
|